174 related articles for article (PubMed ID: 25245707)
1. Aetiology and antibiotic resistance issues regarding urological procedures.
Concia E; Azzini AM
J Chemother; 2014 Oct; 26 Suppl 1():S14-23. PubMed ID: 25245707
[TBL] [Abstract][Full Text] [Related]
2. Clinical aspects of antimicrobial prophylaxis for invasive urological procedures.
Mirone V; Franco M
J Chemother; 2014 Oct; 26 Suppl 1():S1-S13. PubMed ID: 25245706
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological aspects of the antibiotics used for urological diagnostic procedures.
Mazzei T; Diacciati S
J Chemother; 2014 Oct; 26 Suppl 1():S24-34. PubMed ID: 25245708
[TBL] [Abstract][Full Text] [Related]
4. Fosfomycin trometamol (3,000 mg) in perioperative antibiotic prophylaxis of healthcare-associated infections after endourological interventions: a narrative review.
Wagenlehner FM; Thomas PM; Naber KG
Urol Int; 2014; 92(2):125-30. PubMed ID: 24051657
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
[TBL] [Abstract][Full Text] [Related]
6. [Perioperative antibiotic prophylaxis for major urological interventions].
Magistro G; Stief CG; Gratzke C
Urologe A; 2014 Oct; 53(10):1482-8. PubMed ID: 25230809
[TBL] [Abstract][Full Text] [Related]
7. Fosfomycin for the treatment of resistant gram-negative bacterial infections. Insights from the Society of Infectious Diseases Pharmacists.
Reffert JL; Smith WJ
Pharmacotherapy; 2014 Aug; 34(8):845-57. PubMed ID: 24782335
[TBL] [Abstract][Full Text] [Related]
8. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
Garau J
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
[TBL] [Abstract][Full Text] [Related]
9. Surgical site infections may be reduced by shorter duration of prophylactic antibiotic medication in urological surgeries.
Shigemura K; Arakawa S; Yamashita M; Yasufuku T; Fujisawa M
Jpn J Infect Dis; 2009 Nov; 62(6):440-3. PubMed ID: 19934535
[TBL] [Abstract][Full Text] [Related]
10. [Prudent use of antimicrobial prophylaxis : Prevention of increasing antibiotic resistance].
Hein C; Pilatz A; Wagenlehner FME
Urologe A; 2017 Sep; 56(9):1109-1115. PubMed ID: 28631121
[TBL] [Abstract][Full Text] [Related]
11. [Fosfomycin: past, present and future].
Baylan O
Mikrobiyol Bul; 2010 Apr; 44(2):311-21. PubMed ID: 20549968
[TBL] [Abstract][Full Text] [Related]
12. [Fosfomycin--its significance for treatment of diseases due to multidrug-resistant bacteria].
Stock I
Med Monatsschr Pharm; 2015 Jan; 38(1):4-11. PubMed ID: 26349119
[TBL] [Abstract][Full Text] [Related]
13. Assessment of a protocol for prophylactic antibiotics to prevent perioperative infection in urological surgery: a preliminary study.
Kanamaru S; Terai A; Ishitoya S; Kunishima Y; Nishiyama H; Segawa T; Nakamura E; Kinoshita H; Moroi S; Ito N; Kamoto T; Okuno H; Habuchi T; Senda K; Ichiyama S; Ogawa O; Yamamoto S
Int J Urol; 2004 Jun; 11(6):355-63. PubMed ID: 15157202
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics.
Alhambra A; Cuadros JA; Cacho J; Gómez-Garcés JL; Alós JI
J Antimicrob Chemother; 2004 Jun; 53(6):1090-4. PubMed ID: 15117925
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
[TBL] [Abstract][Full Text] [Related]
16. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
[TBL] [Abstract][Full Text] [Related]
17. [Antibiotic prophylaxis in urology].
Recupero SM; Bientinesi R; Foschi N; Racioppi M; Bassi PF; Sacco E
Urologia; 2014; 81(4):209-17. PubMed ID: 25532466
[TBL] [Abstract][Full Text] [Related]
18. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
[TBL] [Abstract][Full Text] [Related]
19. Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.
Al-Zarouni M; Senok A; Al-Zarooni N; Al-Nassay F; Panigrahi D
Med Princ Pract; 2012; 21(6):543-7. PubMed ID: 22722224
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic prophylaxis in urological surgery, a European viewpoint.
Grabe M
Int J Antimicrob Agents; 2011 Dec; 38 Suppl():58-63. PubMed ID: 21996404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
